(Q45240370)

English

Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial (English)

1 reference

Europe PubMed Central

11 December 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

Johnny Ludvigsson

1

1 reference

Europe PubMed Central

11 December 2017

author name string

M Hjorth

2

1 reference

Europe PubMed Central

11 December 2017

M Chéramy

3

1 reference

Europe PubMed Central

11 December 2017

S Axelsson

4

1 reference

Europe PubMed Central

11 December 2017

M Pihl

5

1 reference

Europe PubMed Central

11 December 2017

G Forsander

6

1 reference

Europe PubMed Central

11 December 2017

N-Ö Nilsson

7

1 reference

Europe PubMed Central

11 December 2017

B-O Samuelsson

8

1 reference

Europe PubMed Central

11 December 2017

T Wood

9

1 reference

Europe PubMed Central

11 December 2017

J Aman

10

1 reference

Europe PubMed Central

11 December 2017

E Ortqvist

11

1 reference

Europe PubMed Central

11 December 2017

R Casas

12

1 reference

Europe PubMed Central

11 December 2017

publication date

30 November 2010

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

54

1 reference

Europe PubMed Central

11 December 2017

3

1 reference

Europe PubMed Central

11 December 2017

634-640

1 reference

Europe PubMed Central

11 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-010-1988-1

0 references

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Blockade of interleukin 1 in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Insulin as a primary autoantigen for type 1A diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Immunomodulation with human recombinant autoantigens

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1988-1

21 January 2018

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials of cyclosporin in IDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-010-1988-1

1 reference

Europe PubMed Central

11 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45240370&oldid=2070985186"